Endogenous histamine inhibits the development of morphine-induced conditioned place preference

Acta Pharmacol Sin. 2007 Jan;28(1):10-8. doi: 10.1111/j.1745-7254.2007.00470.x.

Abstract

Aim: The conditioned place preference (CPP) paradigm was used to investigate the effects of endogenous histamine on the processes leading to morphine-induced reward-seeking behavior in Sprague-Dawley rats.

Methods: The model of CPP was used to assess the rewarding effect of morphine. The levels of histamine, glutamate, gamma-aminobutyric acid (GABA), dopamine (DA) and 3, 4-dihydroxyphenylacetic acid (DOPAC) in rat brains were measured with high-performance liquid chromatography. Immunohistochemistry technique was used to observe the morphological changes of neurons.

Results: Intraperitoneal injection of morphine (2, 5 or 10 mg/kg) induced the development of CPP in a dose-dependent manner. In addition, morphine administrations (10 mg/kg) decreased the histamine content and reduced the number and size of histaminergic neurons in the tubero-mammillary nucleus (TM), as well as markedly increasing the DOPAC/DA ratios in the ventral tegmental area (VTA) and nucleus accumbens (NAc). Intraperitoneal injection of histidine (50, 100 or 200 mg/kg) dose-dependently inhibited the development of morphine-induced CPP. Bilateral lesions of the TM, which decreased the histamine levels in the VTA and NAc, potentiated the development of CPP induced by morphine (1 mg/kg, a dose that produced no appreciable effect when given alone) and increased the DOPAC/DA ratios in the VTA and NAc, but did not change the glutamate or GABA levels in these nuclei. Histidine reversed the effects of the TM lesions.

Conclusion: These results indicate that endogenous histamine plays a role in inhibiting the development of morphine-induced reward-seeking behavior, and the inhibition may involve the modulation of dopaminergic activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3,4-Dihydroxyphenylacetic Acid / metabolism
  • Analgesics, Opioid / administration & dosage
  • Analgesics, Opioid / pharmacology
  • Animals
  • Conditioning, Operant / drug effects*
  • Conditioning, Operant / physiology
  • Dopamine / metabolism
  • Dose-Response Relationship, Drug
  • Glutamic Acid / metabolism
  • Histamine / metabolism
  • Histamine / physiology*
  • Histidine / administration & dosage
  • Histidine / pharmacology
  • Hypothalamic Area, Lateral / drug effects
  • Hypothalamic Area, Lateral / metabolism
  • Hypothalamic Area, Lateral / physiology
  • Injections, Intraperitoneal
  • Male
  • Morphine / administration & dosage
  • Morphine / pharmacology*
  • Nucleus Accumbens / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Ventral Tegmental Area / metabolism
  • gamma-Aminobutyric Acid / metabolism

Substances

  • Analgesics, Opioid
  • 3,4-Dihydroxyphenylacetic Acid
  • Glutamic Acid
  • Histidine
  • gamma-Aminobutyric Acid
  • Morphine
  • Histamine
  • Dopamine